Product Information
VERAPAMIL 40 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1174 per EA under NDC 00591040401. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 29, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591040401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072924FDA Approved
6/29/1993
TE Code
AB
On Market Since
6/29/1993
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL 40 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1174 per EA |
|---|---|
| All-time high | $0.1531 (Jan 11, 2017) |
| All-time low | $0.1060 (Jul 17, 2024) |
| 52-week high | $0.1330 |
| 52-week low | $0.1174 |
| Median price | $0.1368 |
| Average price | $0.1355 |
| Largest weekly change | +25.0% (Feb 22, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Verapamil Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL 40 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1174 per EA (NDC 00591040401), effective Aug 19, 2026.
How has the price of VERAPAMIL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL 40 MG TABLET has declined 19.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL 40 MG TABLET?
Since Nov 28, 2013, the NADAC for VERAPAMIL 40 MG TABLET has ranged from a low of $0.1060 (Jul 17, 2024) to a high of $0.1531 (Jan 11, 2017), with a median of $0.1368 per EA.
Are there cheaper alternatives to VERAPAMIL 40 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VERAPAMIL 40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VERAPAMIL 40 MG TABLET?
VERAPAMIL 40 MG TABLET (NDC 00591040401) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.